07:16 AM EDT, 08/09/2024 (MT Newswires) -- Evolent Health ( EVH ) reported Q2 adjusted earnings Friday of $0.30 per share, up from $0.14 a year earlier.

Analysts polled by Capital IQ expected $0.25.

Revenue for the quarter ended June 30 was $647.1 million, up from $469.1 million a year earlier.

Analysts polled by Capital IQ expected $636.4 million.

Evolent now expects full-year 2024 revenue of $2.56 billion to $2.6 billion, from its previous guidance of $2.53 billion to $2.60 billion. Analysts polled by Capital IQ expect $2.58 billion.

For Q3, the company expects revenue of $615 million to $635 million. Analysts polled by Capital IQ expect $642.9 million.

Shares of the company were up 15% in recent Friday premarket activity.

Price: 24.05, Change: +3.18, Percent Change: +15.24